APA (7th ed.) Citation

HS, V., RN, J., A, V., KK, U., MC, T., M, B., & RV, D. (2023). CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function. Antioxidants (Basel, Switzerland), 12(5), . https://doi.org/10.3390/antiox12050997

Chicago Style (17th ed.) Citation

HS, Vyas, Jadeja RN, Vohra A, Upadhyay KK, Thounaojam MC, Bartoli M, and Devkar RV. "CORM-A1 Alleviates Pro-Atherogenic Manifestations via MiR-34a-5p Downregulation and an Improved Mitochondrial Function." Antioxidants (Basel, Switzerland) 12, no. 5 (2023). https://doi.org/10.3390/antiox12050997.

MLA (9th ed.) Citation

HS, Vyas, et al. "CORM-A1 Alleviates Pro-Atherogenic Manifestations via MiR-34a-5p Downregulation and an Improved Mitochondrial Function." Antioxidants (Basel, Switzerland), vol. 12, no. 5, 2023, https://doi.org/10.3390/antiox12050997.